SCHEMBL9749349

SCHEMBL9749349

C#CCOC(=O)Nc1ccc(Cl)c(C(=O)O)c1

nearest known ligand 0.55

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
AGPAT2 O15120 13/20 0.55
KDM4E B2RXH2 2/20 0.50
POLB P06746 2/20 0.50
TDP1 Q9NUW8 2/20 0.50
ALDH1A1 P00352 2/20 0.50
NPC1 O15118 1/20 0.50
MAPT P10636 1/20 0.50
RAB9A P51151 1/20 0.50
CYP1A2 P05177 1/20 0.50
CYP2D6 P10635 1/20 0.50
CYP2C9 P11712 1/20 0.50
PKM P14618 1/20 0.50
HPGD P15428 1/20 0.50
CYP2C19 P33261 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9745408 0.77 RAB9A (0.68) KDM4EPOLBTDP1ALDH1A1NPC1
SCHEMBL6402493 0.75 MEN1 (0.71) ALDH1A1NPC1RAB9ACYP1A2CYP2D6
SCHEMBL1854623 0.73 MAPT (0.54) KDM4EPOLBTDP1ALDH1A1NPC1
SCHEMBL27344589 0.73 HPGD (0.58) AGPAT2KDM4EPOLBTDP1ALDH1A1
SCHEMBL30640612 0.73 MAPT (0.54) KDM4EPOLBTDP1ALDH1A1NPC1
SCHEMBL2499018 0.73 KDM4E (0.66) KDM4EPOLBTDP1ALDH1A1NPC1
SCHEMBL31619607 0.73 KDM4E (0.66) KDM4EPOLBTDP1ALDH1A1NPC1
SCHEMBL31541259 0.73 MAPT (0.47) AGPAT2MAPTPKM
SCHEMBL7258809 0.72 AGPAT2 (1.00) AGPAT2MAPT
SCHEMBL10192052 0.72 NPC1 (0.51) AGPAT2POLBTDP1ALDH1A1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0497816-A1 TREATMENT OF HIV INFECTIONS AND COMPOUNDS USEFUL THEREIN. UNIROYAL CHEMICAL LTD (CA) 1992-08-12 EP disclosed
WO-1991005761-A1 TREATMENT OF HIV INFECTIONS AND COMPOUNDS USEFUL THEREIN UNIROYAL CHEMICAL LTD./UNIROYAL CHEMICAL LTEE (CA) 1991-05-02 WO disclosed